About Amylyx Pharmaceuticals, Inc. 
Amylyx Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 45 Schemes (37.82%)
Foreign Institutions
Held by 89 Foreign Institutions (10.79%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2026)
Net Profit:
-43 Million
Pharmaceuticals & Biotechnology
USD 1,498 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.03
-47.41%
4.91
Footer loading






